<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045276"><TermName>Piritrexim</TermName><TermPronunciation>(peer-ee-TREK-sim)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate antagonists.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705249" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Piritrexim&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705248" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Piritrexim&quot;" language="es" id="_4"/><SpanishTermName>Piritrexim</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de c√°ncer. Pertenece al tipo de medicamentos llamados antagonistas del folato.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-03-02</DateLastModified></GlossaryTerm>
